ATE344326T1 - Lkta deletionsmutanten in p. haemolytica - Google Patents

Lkta deletionsmutanten in p. haemolytica

Info

Publication number
ATE344326T1
ATE344326T1 AT98949510T AT98949510T ATE344326T1 AT E344326 T1 ATE344326 T1 AT E344326T1 AT 98949510 T AT98949510 T AT 98949510T AT 98949510 T AT98949510 T AT 98949510T AT E344326 T1 ATE344326 T1 AT E344326T1
Authority
AT
Austria
Prior art keywords
haemolytica
lkta
deletion mutants
mutants
ruminants
Prior art date
Application number
AT98949510T
Other languages
English (en)
Inventor
Robert E Briggs
Fred M Tatum
Original Assignee
Biotechnology Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Res & Dev filed Critical Biotechnology Res & Dev
Application granted granted Critical
Publication of ATE344326T1 publication Critical patent/ATE344326T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
AT98949510T 1997-09-25 1998-09-25 Lkta deletionsmutanten in p. haemolytica ATE344326T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6006097P 1997-09-25 1997-09-25

Publications (1)

Publication Number Publication Date
ATE344326T1 true ATE344326T1 (de) 2006-11-15

Family

ID=22027061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98949510T ATE344326T1 (de) 1997-09-25 1998-09-25 Lkta deletionsmutanten in p. haemolytica

Country Status (11)

Country Link
US (3) US6331303B1 (de)
EP (1) EP1017822B1 (de)
AT (1) ATE344326T1 (de)
AU (1) AU743654B2 (de)
CA (1) CA2303390C (de)
DE (1) DE69836341T2 (de)
DK (1) DK1017822T3 (de)
ES (1) ES2279582T3 (de)
NZ (2) NZ503463A (de)
PT (1) PT1017822E (de)
WO (1) WO1999015670A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US7304151B2 (en) 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
US20020058265A1 (en) * 2000-09-15 2002-05-16 Promega Corporation Detection of microsatellite instability and its use in diagnosis of tumors
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
EP3384927B1 (de) * 2012-11-08 2022-07-06 Boehringer Ingelheim Animal Health USA Inc. Attenuierte mannheimia-haemolytica-impfstoffe sowie verfahren zur herstellung und verwendung
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
BR112017003462B1 (pt) 2014-09-03 2023-02-14 Intervet International B.V. Coronavírus bovino atenuado e vacina
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US11679150B2 (en) * 2020-03-03 2023-06-20 The United States Of America, As Represented By The Secretary Of Agriculture Mycoplasma bovis vaccine product
WO2025157994A1 (en) 2024-01-25 2025-07-31 Intervet International B.V. Vaccine against ruminant respiratory disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AUPN631395A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae

Also Published As

Publication number Publication date
US6331303B1 (en) 2001-12-18
DE69836341D1 (de) 2006-12-14
NZ503463A (en) 2002-10-25
PT1017822E (pt) 2007-02-28
CA2303390C (en) 2010-02-23
AU743654B2 (en) 2002-01-31
AU9581798A (en) 1999-04-12
US6495145B2 (en) 2002-12-17
DE69836341T2 (de) 2007-05-31
DK1017822T3 (da) 2007-03-12
EP1017822B1 (de) 2006-11-02
NZ514103A (en) 2001-09-28
ES2279582T3 (es) 2007-08-16
US6573093B2 (en) 2003-06-03
US20020039589A1 (en) 2002-04-04
CA2303390A1 (en) 1999-04-01
US20020086413A1 (en) 2002-07-04
WO1999015670A1 (en) 1999-04-01
EP1017822A1 (de) 2000-07-12

Similar Documents

Publication Publication Date Title
DE69836341D1 (de) Lkta deletionsmutanten in p. haemolytica
DE69330294D1 (de) Inter-hierarchisches Synchronisationssystem und LSI, das dieses System verwendet
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
GB9818916D0 (en) Use
IT1158039B (it) 2-/4-/(4,4-dialchil-2,6-piperidindion-1-il)-butil/1-piperazinil/pirimidine ad attivita' ansiolitica selettiva, procedimento per la loro preparazione e preparati farmaceutici che le contengono
IL64485A (en) Antibiotic a-4696 factors b1,b2,b3,c1a,c3 and e1,their preparation and use as animal feed supplement
FI931499A7 (fi) Syklopeptidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääke aineina
NO904342D0 (no) Fiskevaksine omfattende en virulent, inntrengende bakterie
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
FI852003A7 (fi) --laktaamiantibiootteja, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineina tai kasvunedistäjinä karjankasvatuksessa tai hapettumisen estoaineina.
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
NZ511366A (en) Virulence genes and proteins, and their use
FR2748476B1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
GB9810084D0 (en) Proteins
IE45136L (en) Rearing of animals
IL82727A0 (en) New tylosin resistance-conferring gene,designated tlrb,for use in streptomyces and other organisms
DE3879492D1 (de) Hexafluoroneopentyl alkohol, dessen derivate, fluorierte polymere und deren verwendung.
ES2020176B3 (es) Composicion de apresto de alcohol polivinilico de actividad elevada en tejidos, poco espumosa.
CU21549A1 (en) Antidiarrhoea enterotixic by e,coli vaccin in calves,their obtainment procedure and the culture media
IT206896Z2 (it) Iniettore per la fecondazione artificiale in particolare per suini.
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
GB9824569D0 (en) Virulence gene and protein,and their use
RU93011685A (ru) Штамм актиномицета streptomyces ornatus - продуцент внеклеточного кератинрасщепляющего фермента
BG103733A (en) Isolated genes and proteins encoding resistance to photosensibilizers
Martinez et al. Search for Yersinia enterocolitica in healthy humans.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties